Search Results (1,599)

In the present research, a new type of biomimetic material loaded with chlorophyll derivatives (CpDs) for photodynamic therapy based on poly(3-hydroxybutyrate) (PHB) was fabricated by the electrospinning method. Such matrices showed great potential for the advanced delivery of photodynamic therapeutic reagents to targeted regions and options for prolonged local application. The key morphological characteristics of fibrous materials were investigated. It was found that incorporation of CpDs leads to a change in the average fiber diameter from 3.5 µm to 2.1 µm, increasing porosity from 80% to 90% and accompanied by an over 3-fold increased proportion of open pores. Moreover, the CpD application facilitated fine hydrophilicity tuning, allowing an increase of this parameter up to 10% under different conditions, neutralizing the hydrophobic nature of the matrix polymer and photosensitizer. Moreover, changes in physical properties, supramolecular structure, photosensitizing effect, and singlet oxygen generation were investigated. The data obtained show that the proposed materials are great examples of convenient and reliable carriers for advanced PDT. The results obtained demonstrate high antimicrobial activity in the presence of irradiation as well as noticeable efficacy against carcinoma, both light and dark. Full article

Background/Objectives: Metabolic dormancy in biofilms leads to reduced drug efficacy in these communities. Different pharmacokinetics and adverse side effects complicate the simultaneous delivery of multiple drugs at appropriate concentrations to the infection site. This study aimed to develop chitosan-coated mesoporous silica nanoparticles loaded with curcumin and amphotericin B (CS@MSNs-Cur-AmB) and to evaluate their antibiofilm activity combined with antimicrobial photodynamic therapy (PDT) against Streptococcus mutans and Candida albicans dual-species biofilms. Methods: CS@MSNs-Cur-AmB were developed. The structure and morphology of the nanoparticles were evaluated using Fourier transform-infrared spectroscopy (FTIR), zeta potential, field emission scanning electron microscopy (FESEM), and thermogravimetric analysis (TGA). Cytotoxicity toward human gingival fibroblasts was assessed. Colony-forming units per milliliter (CFU/mL) were determined. The metabolic activity of biofilm-forming cells was measured using the tetrazolium (MTT) assay. Results: Physicochemical analyses confirmed the synthesis of CS@MSNs-Cur-AmB, revealing a particle size of 228 nm and thermal stability up to 600 °C. Cytotoxicity assays showed that CS@MSNs-Cur-AmB exhibited good biocompatibility (> 90%). CS@MSNs-Cur-AmB improved antimicrobial activity, which was further enhanced by blue light-emitting diode (LED) irradiation. CS@MSNs-Cur-AmB under LED irradiation showed the strongest effect, reducing metabolic activity to 27.74 ± 4.08% (1 W/cm², 1 min), p < 0.001). Conclusions: Formulating two drugs in nanocarrier systems may improve therapeutic efficacy by increasing local concentration and reducing systemic exposure. This offers an effective strategy for combating oral biofilms. Full article

Cannabidiol (CBD), a major non-psychoactive phytocannabinoid, has attracted considerable attention owing to its broad therapeutic potential. Its anti-inflammatory, antimicrobial, and antitumor properties make it a promising candidate for the treatment of mucosa-associated diseases. However, the clinical translation of CBD is significantly hindered by its unfavorable physicochemical properties, particularly high lipophilicity and poor aqueous solubility, which result in low bioavailability. To overcome these limitations, the rational selection of administration routes in combination with advanced drug delivery systems tailored to disease pathophysiology is essential. Such strategies are critical for improving the stability of CBD, enhancing mucosal permeation, and enabling controlled and targeted release at diseased sites. Nevertheless, a systematic review focusing on these aspects is still lacking. This review first summarizes the relationship between CBD and the mucosal endocannabinoid system, together with its pharmacological effects. It then discusses the therapeutic potential of CBD in mucosal disorders of the digestive and respiratory systems. In addition, current administration routes and advanced delivery systems for CBD are reviewed to provide insights for future research and clinical translation. Finally, the remaining challenges associated with the clinical application of CBD and future development directions are discussed. Full article

Apitherapy is a complementary therapeutic approach based on the use of bee-derived products, particularly bee venom (BV), also known as apitoxin. Bee venom is a complex mixture of biologically active compounds, including peptides, enzymes, and biogenic amines, that exhibit diverse pharmacological activities. Major bioactive constituents such as melittin, apamin, adolapin, and phospholipase A2 have attracted increasing scientific interest due to their anti-inflammatory, antioxidant, antimicrobial, analgesic, and immunomodulatory properties. This review provides a comprehensive overview of the biological effects and therapeutic potential of bee venom in the management of chronic diseases, particularly diabetes, cancer, and neurological disorders. Evidence from experimental and clinical studies suggests that BV and its components can modulate multiple molecular pathways associated with oxidative stress, inflammation, apoptosis, and immune responses. These mechanisms contribute to potential benefits in glycemic control, tumor suppression, neuroprotection, and pain management. Additionally, bee venom has been investigated for its capacity to influence signaling pathways involved in cellular proliferation and survival, highlighting its potential as a complementary strategy in the treatment of complex diseases such as neurodegenerative disorders, including Parkinson’s and Alzheimer’s diseases. Despite these promising therapeutic effects, the clinical use of BV remains limited due to safety concerns, particularly the risk of allergic reactions, systemic toxicity, and anaphylaxis. Recent advances in drug delivery systems and nanotechnology may help improve the safety and efficacy of BV-based therapies by enabling targeted delivery and controlled dosing. Overall, bee venom represents a promising source of bioactive compounds with potential applications in translational and integrative medicine; however, further well-designed clinical trials and mechanistic studies are necessary to establish its safety, efficacy, and long-term therapeutic value. Full article

Bacterial sexually transmitted and sexually associated infections remain a major global health concern, increasingly complicated by antimicrobial resistance and the limited effectiveness of existing therapies. In this context, bacteriophage-based and phage-derived approaches have re-emerged as potential alternative antibacterial strategies. This narrative review examines their applicability across key bacterial pathogens associated with sexually transmitted infections, including Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Treponema pallidum and biofilm-associated bacterial vaginosis, with a particular focus on pathogen-specific biological barriers. Available evidence indicates that the success of phage-based interventions is strongly dependent on factors such as intracellular localisation, structural characteristics of the bacterial envelope and the presence of polymicrobial biofilms. While phage-derived platforms, including endolysins, depolymerases and engineered phages, demonstrate antibacterial activity in experimental settings, their effectiveness is uneven across different pathogens. Biofilm-associated infections appear more accessible to these approaches, whereas intracellular and structurally atypical bacteria are currently considered more challenging targets based on available mechanistic and experimental evidence. These observations highlight the need for pathogen-specific engineering strategies and delivery systems. Overall, phage-based therapeutics in this field should be considered within a framework that integrates biological constraints with targeted antimicrobial design. Full article

Next-generation vaccines are being developed to elicit durable and cross-protective immune responses against diverse pathogens, particularly those targeting the respiratory and enteric systems. By strategically engaging T cell-centric antigen design, mucosal immune engagement, and induction of trained innate immunity, these innovative platforms are expected to reshape the paradigm of immunoprophylaxis and to offer promising avenues for enhanced protection against complex infectious diseases. Conventional antibody-based vaccines, though effective against many infections, often lack the capacity to induce durable or cross-protective immunity at mucosal surfaces. Advances in antigen design, delivery platforms, and adjuvant technologies now facilitate precise activation of tissue-resident memory T cells and enhancement of mucosal secretory IgA responses, thereby achieving sterilizing immunity at barrier surfaces while reinforcing systemic immune protection. Advanced delivery platforms, including lipid nanoparticles, viral vectors, and nano or liposomal carriers, further refine antigen presentation, enhancing stability, targeting, and overall immunogenicity. Concurrently, progress in understanding trained innate immunity highlights opportunities to induce broad, non-antigen-specific protection through epigenetic and metabolic reprogramming of innate cells. The integration of these adaptive and innate mechanisms may enhance early pathogen control, limits transmission, and strengthens defense against variant and antimicrobial-resistant pathogens across diverse populations. However, translating these immunological insights into safe, scalable, and globally accessible vaccines remains a major challenge. This review explores the emerging conceptual framework of next-generation vaccines that demonstrate partial integration of these axes in preclinical models, though human translation and functional synergy require Phase II validation. It highlights progress toward next-generation vaccines leveraging integrated adaptive and innate immune reprogramming for superior protection against respiratory and enteric pathogens. Full article

Carbon dots (CDs), including carbon quantum dots (CQDs), are ultra-small carbon-based nanomaterials, typically below 10 nm, with tunable photoluminescence, high aqueous dispersibility, favorable biocompatibility, low toxicity, and abundant surface functional groups. These properties make CDs promising multifunctional platforms for nanomedicine, particularly in bioimaging, biosensing, targeted drug/gene delivery, photodynamic therapy (PDT), photothermal therapy (PTT), antimicrobial treatment, and theranostic applications. This review critically examines recent advances in CD fabrication, including top-down, bottom-up, green biomass-derived, microwave-assisted, hydrothermal, and emerging hybrid strategies, with emphasis on how precursor selection, heteroatom doping, surface passivation, and polymer/ligand functionalization regulate optical performance, biological interaction, and therapeutic efficiency. The review discusses structural classification, including CQDs, graphene quantum dots (GQDs), carbon nanodots, and carbonized polymer dots (CPDs), together with major characterization approaches such as ultraviolet–visible (UV–Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), Raman spectroscopy, and high-resolution transmission electron microscopy (HRTEM). Particular attention is given to red/near-infrared (NIR) emission, renal clearance, drug-loading behavior, reactive oxygen species (ROS) generation, toxicity mechanisms, biodistribution, and long-term biosafety. This review also highlights key translational barriers, including batch-to-batch variability, limited standardization, scalable manufacturing, regulatory uncertainty, and incomplete pharmacokinetic evaluation. It considers artificial intelligence (AI) and machine learning (ML) as emerging tools for reproducible CD design. CDs represent versatile and clinically promising nanoplatforms, but their translation requires standardized synthesis, rigorous safety assessment, and application-specific regulatory validation. Full article

Silver nanoparticles (AgNPs) have attracted substantial scientific interest in biomedical research owing to their unique physicochemical characteristics, broad-spectrum antimicrobial activity, plasmonic properties, and therapeutic versatility. Although conventional physicochemical synthesis methods enable controlled NPs fabrication, their dependence on hazardous reagents, elevated energy input, and environmentally detrimental processing conditions has stimulated the development of sustainable biogenic alternatives. Biological synthesis utilizing plants, microorganisms, fungi, algae, and purified biomolecules has emerged as an eco-friendly and bio-compatible strategy for AgNP fabrication, enabling simultaneous reduction, stabilization, and intrinsic biofunctionalization of NPs. However, traditional biogenic synthesis remains constrained by limited mechanistic understanding, poor batch reproducibility, inadequate control over physicochemical properties, and challenges in large-scale manufacturing. Recent advances in bioengineering have transformed this field through the integration of metabolic engineering, synthetic biology, microfluidic-assisted synthesis, artificial intelligence-guided process optimization, and continuous-flow biomanufacturing, collectively enabling precision fabrication of biogenic AgNPs with enhanced uniformity, scalability, and functional tunability. Furthermore, strategic surface engineering and functionalization have expanded the applicability of biogenic AgNPs across targeted anticancer therapy, antimicrobial intervention, wound healing, regenerative medicine, drug delivery, and theranostic imaging. Despite these advancements, critical challenges remain regarding nano–bio interactions, toxicological safety, regulatory compliance, and translational scalability. Unlike conventional reviews focused primarily on green synthesis approaches, this review critically highlights emerging bioengineering paradigms that enable programmable, scalable, and precision-controlled biogenic AgNP fabrication. This review comprehensively examines next-generation paradigms and strategies for AgNPs biosynthesis, elucidates the molecular mechanisms governing their formation, highlights emerging functionalization and biomedical application paradigms, and discusses current translational barriers. Forming biogenic composites of AgNPs and heteroatom doped carbon nanodots needs intense research in near future. Full article

The emerging threat of antibiotic-resistant pathogens and the limitations that conventional cancer chemotherapies display have created an urgent need for the development of innovative therapeutic strategies. Combining the pleiotropic biological roles of antimicrobial peptides (AMPs) and nanomaterials through their conjugation presents a promising possibility of targeting both microbial membranes and malignant cells. In the present study, we engineered a novel bioactive material by immobilizing the insect-derived AMP Papiliocin onto multi-walled—decorated with polyethylene–glycol—carbon nanotubes (PEG-MWCNTs) to prevent proteolytic degradation of the peptide and enhance its cellular delivery. Recombinant Papiliocin was cloned, heterologously expressed, purified and conjugated onto the PEG-MWCNT carrier. Successful expression and conjugation were validated via immunoblotting and Fourier transform infrared (FT-IR) spectroscopy, respectively. Further physicochemical characterization of the bionanocomposites was conducted using Dynamic Light Scattering (DLS) and Zeta potential measurements. Biologically, the biofunctionalized material exhibited potent, broad-spectrum antimicrobial activity both on Staphylococcus aureus and Escherichia coli, inhibiting almost 90% of the latter’s growth, highlighting the bioconjugate’s specific interactions with the Gram-negative pathogens’ membranes. Furthermore, it significantly reduced biofilm formation in Candida albicans, as indicated by the TCP assay. In parallel with its antimicrobial effects, CNTs-PEG–Papiliocin significantly reduced cancer cell viability and induced apoptosis via the extrinsic apoptosis pathway in HeLa cells, a response assisted by efficient intracellular delivery. Notably, cytotoxicity assays demonstrated lesser cytotoxic effect against non-tumorigenic HaCaT cells relative to the cancerous cell line. Collectively, these findings indicate the Papiliocin–biofunctionalized CNTs as a versatile, dual-action therapeutic agent with potential for antimicrobial activity and anticancer mode of action. Full article

Polymer-based dressings constitute an important class of macromolecular biomaterials enabling controlled drug delivery and enhanced wound healing performance. This review summarizes recent advances in the design, fabrication, and functionalization of polymer dressings, with emphasis on natural and synthetic polymer systems applied in biomedical topical and transdermal drug administration. Key material properties, including biocompatibility, mechanical stability, porosity, and degradation behavior, are discussed in relation to drug loading capacity and release kinetics. Current fabrication strategies, such as electrospinning, hydrogel formation, casting, and multilayer assembly, are critically evaluated with respect to structural control and scalability. Particular attention is given to antimicrobial and stimuli-responsive platforms capable of dynamic interaction with the wound microenvironment. Furthermore, challenges related to long-term stability, regulatory requirements, and clinical translation are addressed. By integrating recent experimental findings, this review highlights essential structure–function relationships governing polymer dressing performance and provides design guidelines for next-generation macromolecular topical and transdermal care systems with improved multifunctionality and clinical applicability. Full article

The development of biocompatible functional nanostructures has emerged as a key driver in advancing nanomedicine, environmental remediation, and sustainable energy technologies. However, conventional synthesis methods often rely on toxic reagents, hazardous solvents, and energy-intensive processes, raising significant concerns regarding environmental impact and biological safety. In this context, green synthesis has gained increasing attention as a sustainable alternative, utilizing biological systems, renewable resources, and environmentally benign solvents to produce functional nanomaterials. This mini-review provides an overview of recent advances in the green synthesis of organic, inorganic, and hybrid nanostructures, highlighting their physicochemical properties and functional performance. Particular emphasis is placed on their applications in nanomedicine, including drug delivery, bioimaging, antimicrobial and anticancer therapies, and theranostic platforms. Additionally, their roles in environmental applications, such as pollutant degradation and water treatment, and in energy-related systems, including catalysis, solar energy conversion, and energy storage, are discussed with selected representative examples. Despite significant progress, key challenges remain, including limited mechanistic understanding, reproducibility issues, scalability constraints, and uncertainties related to long-term toxicity and environmental impact. Addressing these limitations will be essential for the safe and large-scale implementation of green nanotechnology. Overall, the integration of green chemistry principles with advanced nanomaterial design offers a promising pathway toward the development of multifunctional, sustainable, and high-performance nanostructures capable of addressing global health, environmental, and energy challenges. Full article

Marine macroalgae are a rich source of bioactive natural products, although the application of many lipophilic compounds is limited by poor aqueous solubility and instability. This study investigated metabolites isolated from the South African brown seaweed Sargassum incisifolium and evaluated a solid lipid nanoparticle (SLN) system to improve their physicochemical properties and enable bioactivity studies. Five metabolites, including one previously unreported derivative and four known metabolites (including fucoxanthin), were isolated and characterized using standard chromatographic and spectroscopic techniques. SLNs composed of stearic acid and Poloxamer 188 were prepared via hot homogenization and characterized using dynamic light scattering, scanning electron microscopy, thermogravimetric analysis, and NMR, which confirmed the efficient encapsulation of the lipophilic compounds. Antimicrobial activity against clinically relevant bacterial and fungal pathogens was evaluated using a resazurin-based microdilution assay, with results expressed as percentage growth relative to untreated controls. The pure compounds exhibited moderate, concentration-dependent activity, while the SLN formulations improved dispersibility, and in several cases, reduced % growth or produced more consistent responses, particularly against Gram-positive bacteria and Candida auris. Although activity remained lower than that of conventional antimicrobials, these findings demonstrate that SLN-based delivery enables functional evaluation of hydrophobic marine metabolites and supports further development of Sargassum-derived natural products. Full article

Background: Antibiotic-free approaches to boar semen preservation are gaining importance to counter emerging antimicrobial resistance. Hypothermic storage at 5 °C, instead of the conventional 17 °C, is a promising strategy to eliminate antibiotics still commonly used in extenders. For practical adoption, the method must be simple and compatible with on-farm routines. Objective: To assess fertility when cooling was initiated on farm one day after delivery, and to evaluate the robustness of cold-stored semen to temporary warming and subsequent re-cooling, mimicking typical handling on insemination days. Methods: Individual ejaculates (n = 34) from six boars were extended in Androstar^® Premium either without antibiotics (5 °C) or with gentamicin (17 °C control). One day after collection, antibiotic-free doses were cooled on farm to 5 °C and used alongside controls in routine insemination of 270 sows. Sperm quality was evaluated by computer-assisted semen analysis and flow cytometry, and bacterial counts were monitored. In a separate test, cold-stored doses were exposed to 20 °C for 60 min and re-cooled to 5 °C. Results: Farrowing rates and litter sizes did not differ between groups (p > 0.05). In antibiotic-free samples after 120 h, bacterial counts were mostly not detectable or low (<10² CFU/mL). Sperm motility and plasma membrane integrity in cold-stored doses remained >80%, comparable to controls (p > 0.05). Temporary warming did not affect sperm quality or bacterial counts. Conclusions: Antibiotic-free semen storage at 5 °C is easy to implement in practice and maintains fertility under field conditions. Broader validation under routine conditions is encouraged in support of the One Health concept. Full article

Minimally invasive thread lifting has emerged as an effective strategy for soft tissue repositioning and facial rejuvenation; however, currently used absorbable threads generally lack intrinsic antimicrobial functionality, which may increase the risk of postoperative infection. Here, we report a biodegradable antibacterial lifting thread based on a nanocellulose/MOF composite system. The thread was fabricated via a green wet-spinning strategy using carboxymethylated cellulose nanofibrils (CCNF, prepared with cellulose derived from Astragalus residue) and sodium alginate (SA) as the structural matrix, while tetracycline hydrochloride-loaded ZIF-8 nanoparticles were incorporated to provide sustained antibacterial activity. The resulting antibacterial CCNF/SA thread (AB-CCNF/SA) exhibited a uniform morphology and a tensile strength of 80 MPa. The porous ZIF-8 carriers enabled efficient drug loading and controlled release, providing effective antibacterial activity against Staphylococcus aureus and Escherichia coli. Meanwhile, the composite threads showed favorable biodegradability, with approximately 45% degradation within 56 days, together with excellent cytocompatibility as demonstrated by fibroblast viability above 90%. In vivo studies further revealed inflammatory responses comparable to those of commercial collagen threads, confirming the good biocompatibility of the system. Overall, this work establishes a strategy for integrating nanocellulose structural materials with MOF-enabled antibacterial drug delivery, providing a multifunctional platform that combines mechanical support, biodegradability, and sustained antibacterial activity for minimally invasive soft tissue lifting and related biomedical implant applications. Full article

Ovotransferrin (OVT), a major iron binding glycoprotein in egg white, is increasingly studied as a multifunctional ingredient for food preservation, mineral delivery, and colloidal design. This review critically evaluates how native structure, iron saturation, thermal history, glycation, phosphorylation, fibrillation, and interactions with proteins, polysaccharides, polyphenols, and lipid interfaces influence or determine OVT behavior during processing and gastrointestinal digestion. Rather than defining digestive stability simply as resistance to proteolysis, the review compares how processing routes reshape protease accessibility, peptide release, residual allergenic risk, and the persistence of antimicrobial or antioxidant functions. Particular emphasis is placed on cross-matrix interactions because OVT rarely acts as an isolated purified protein in practical formulations; its performance depends on pH, ionic strength, competing ligands, and the architecture of emulsified, coated, or liquid food systems. The available literature indicates that the most mature application space is multifunctional food system design, including preservation-oriented coatings, Pickering-type emulsions, oleogel-associated systems, and liquid food delivery platforms. Broader industrial applications will require standardized reporting of apo/holo state, processing history, digestion models, real food validation, sensory consequences, and allergenicity. To reduce overinterpretation, the present synthesis prioritizes primary studies and weighs model food or real food validation more heavily than mechanistic or preclinical evidence when discussing application readiness. Overall, OVT should be regarded as a promising but context-dependent protein platform whose value lies in coupling bioactivity with techno-functionality rather than in any single universal health claim. Methodological transparency is further supported by explicit database sources, reproducible search blocks, inclusion/exclusion rules, and a structured quality-appraisal and evidence tiering framework. Full article